Prevalence of antibodies against three species of Leishmania (L. mexicana, L. braziliensis, L. infantum) and possible associated factors in dogs from Mérida, Yucatán, Mexico

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 4, 2012, Pages 252-258

  Arjona Jiménez, Guadalupe ^a   Villegas, Noelia ^b   López Céspedes, Ángeles ^b   Marín, Clotilde ^b   Longoni, Silvia S ^b   Bolio González, Manuel E ^a   Rodríguez Vivas, Roger I ^a   Sauri Arceo, Carlos H ^a   Sánchez Moreno, Manuel ^b  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Dog; Leishmania braziliensis; Leishmania infantum; Leishmania mexicana; SOD serological test; Yucat n (Mexico)

Indexed keywords

PROTOZOON ANTIBODY; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA; MEXICO; NONHUMAN; SEROPREVALENCE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PROTOZOAN; BLOTTING, WESTERN; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA; LEISHMANIASIS; MALE; MEXICO; PREVALENCE;

CANIS FAMILIARIS; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA;

EID: 84858291375     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.12.003     Document Type: Article

References (31)

1. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol 2010, 35:699-705.
2. Joao A., Pereira M.A., Cortes S., Santos-Gómez G.M. Canine Leishmaniasis chemotherapy: Dog's clinical condition and risk of Leishmania transmission. J Vet Med A Physiol Pathol Clin Med 2006, 53:540-545.
3. Tolezano J.E., Uliana S.R., Taniguchi H.H., et al. The first records of Leishmania (Leishmania) amazonensis in dogs (Canis familiaris) diagnosed clinically as having canine visceral leishmaniasis from Aracatuba County, Sao Paulo State. Brazil Vet Parasitol 2007, 149:280-284.
4. Reithinger R., Davies C.R. Is the domestic dog (Canis familiaris) a reservoir host of American cutaneous leishmaniasis?. A critical review of the current evidence. Am J Trop Med Hyg 1999, 61:530-541.
5. Velasco-Castrejón O., Rivas Sánchez B., Mungía Saldaña A., Hobart O. Leishmaniasis cutánea de perros en México [in Spanish]. Enf Inf Microbiol 2009, 29:135-140.
6. Hernández-Montes O., Monroy-Ostria A., McCann S., Barker D.C. Identification of Mexican Leishmania species by analysis of PCR amplified DNA. Acta Trop 1998, 71:139-153.
7. Sánchez-García L., Berzunza-Cruz M., Becker-Fauser I., Rebollar-Tellez E.A. Sand flies naturally infected by Leishmania (L.) mexicana in the peri-urban area of Chetumal city, Quintana Roo, Mexico. Trans R Soc Trop Med Hyg 2010, 104:406-411.
8. Seidelin H. Leishmaniasis and babesiasis in Yucatán. Ann Trop Med Parasitol 1912, 6:295-298.
9. Córdova-Uscanga C., Albertos-Alpuche N.E., Andrade-Narvaez F.J., Canto-Lara S.B. Leishmaniasis: a preliminary epidemiological study in a locality of the endemic area in the state of the Tabasco. Salud Pública Mex 1993, 35:345-350.
10. WHO. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. Geneva: World Health Organization; 2010. WHO/HTM/NTD/2010.1.
11. Ordeix L., Solano-Gallego L., Fondevila D., Ferrer L., Fondati A. Popular dermatitis due to Leishmania spp. infection in dogs with parasite-specific cellular immune responses. Vet Dermatol 2005, 16:187-191.
12. Longoni S.S., Marín C., Sauri-Arceo C.H., et al. Tegumentary leishmaniasis in dogs of the Yucatan Peninsula (Mexico): use of iron-superoxide dismutase excreted as the antigen fraction and its application for screening in epidemiological studies. Vector-Borne Zoonotic Dis 2011, 11:815-821.
13. Reithinger R., Dujardin J.C. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 2007, 45:21-25.
14. Marín C., Longoni S.S., Urbano J., et al. Enzyme-linked immunosorbent assay for superoxide dismutase-excreted antigen in diagnosis of sylvatic and Andean cutaneous leishmaniasis of Peru. Am J Trop Med Hyg 2009, 80:55-60.
15. Mizbani A., Taheri T., Zahedifard F., et al. Recombinant Leishmaia tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis. Vaccine 2009, 28:53-62.
16. Mohapatra T.M., Singh D.P., Sen M.R., Bharti K., Sundar S. Comparative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis. J Infect Dev Ctries 2010, 4:114-117.
17. Paramchuk W.J., Ismail S.O., Bhatia A., Gedamu L. Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: role in pathogenesis. Mo Biochem Parasitol 1997, 90:203-221.
18. Marín C., Longoni S.S., Mateo H., et al. The use of an excreted superoxide dismutase in an ELISA and Western blotting for the diagnosis of Leishmania (Leishmania) infantum naturally infected dogs. Parasitol Rev 2007, 101:801-808.
19. Martins Gonçalves C.C., Vissoci Reiche E.M., Alves de Abreu Filho B., et al. Evaluation of antigens from various Leishmania species in a western blot for diagnosis of American tegumentary leishmaniasis. Am J Trop Med Hyg 2002, 66:91-102.
20. Instituto Nacional de Estadística, Geografía e informática (INEGI). Anuario estadístico del Estado de Yucatán, México. Instituto Nacional de Estadística, Geografía e informática, México. 2002.
21. Thrusfi{ligature}eld M. Veterinary epidemiology 2005, Blackwell Science, Oxford. 3rd ed.
22. Otranto D., Capelli G., Genchi C. Changing distribution patterns of canine vector borne diseases in Italy: leishmaniosis vs dirofilariosis. Parasitol Vectors 2009, 2(Suppl 1):S2.
23. Schnedl J., Auer H., Fischer M., Tomaso H., Pustelnik T., Mooseder G. Cutaneous leishmaniasis--an import from Belize [in German]. Wien Klin Wochenschr 2007, 119:102-105.
24. Zeledón R., Maingon R., Ward R., et al. The characterization of Leishmania parasites and their vectors from Central America using molecular techniques. Arch Inst Pasteur Tunis 1993, 70:325-329.
25. Marín C., Sánchez-Moreno M. The trypanosomiasis diagnosis: A review on the role of the superoxide dismutase as molecular marker. Curr Rev Microbiol 2009, 1:1-12.
26. Dantas-Torres F., de Brito M.E.F., Brandão-Filho S.P. Seroepidemiological survey on canine leishmaniasis among dogs from an urban area of Brazil. Vet Parasitol 2006, 140:54-60.
27. Canese A., Garoso O., Ramírez J., Maidana N., Montini M., Santa-Cruz R. Focos de leishmaniasis visceral canina en las ciudades de Lambare y Villa Elisa Paraguay. Rev Paraguaya de Microbiología 1999, 19:1-15.
28. Fernández J.M., Charry T.A.C., Bello G.F.J., et al. Prevalence of canine visceral leishmaniasis in municipalities of Huila, Colombia. Rev Salud Pública 2002, 4:278-285.
29. Rosypal A.C., Cortés-Vecino J.A., Gennari S.M., Dubey J.P., Tidwell R.R., Lindsay D.S. Serological survey of Leishmania infantum and Tryopanosoma cruzi in dog from urban areas of Brazil and Colombia. Vet Parasitol 2007, 149:172-177.
30. Ibañez-Bernal S. Phlebotominae in Mexico. I. Brumptomyia França and Parrot; Lutzomyia França, the species L. (Lutzomyia) França and group verrucarum [in Spanish?.]. Folia Entomol Mex 1999, 107:61-116.
31. Beyer W.F., Fridovich I. Assaying for superoxide dismutase activity: Some large consequences of minor changes in conditions. Anal Biochem 1987, 161:559-660.